These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 22789497)

  • 21. Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study.
    Dalton T; Cegielski P; Akksilp S; Asencios L; Campos Caoili J; Cho SN; Erokhin VV; Ershova J; Gler MT; Kazennyy BY; Kim HJ; Kliiman K; Kurbatova E; Kvasnovsky C; Leimane V; van der Walt M; Via LE; Volchenkov GV; Yagui MA; Kang H; ; Akksilp R; Sitti W; Wattanaamornkiet W; Andreevskaya SN; Chernousova LN; Demikhova OV; Larionova EE; Smirnova TG; Vasilieva IA; Vorobyeva AV; Barry CE; Cai Y; Shamputa IC; Bayona J; Contreras C; Bonilla C; Jave O; Brand J; Lancaster J; Odendaal R; Chen MP; Diem L; Metchock B; Tan K; Taylor A; Wolfgang M; Cho E; Eum SY; Kwak HK; Lee J; Lee J; Min S; Degtyareva I; Nemtsova ES; Khorosheva T; Kyryanova EV; Egos G; Perez MT; Tupasi T; Hwang SH; Kim CK; Kim SY; Lee HJ; Kuksa L; Norvaisha I; Skenders G; Sture I; Kummik T; Kuznetsova T; Somova T; Levina K; Pariona G; Yale G; Suarez C; Valencia E; Viiklepp P
    Lancet; 2012 Oct; 380(9851):1406-17. PubMed ID: 22938757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome.
    Holtz TH; Sternberg M; Kammerer S; Laserson KF; Riekstina V; Zarovska E; Skripconoka V; Wells CD; Leimane V
    Ann Intern Med; 2006 May; 144(9):650-9. PubMed ID: 16670134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
    van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S
    Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baseline Predictors of Treatment Outcomes in Children With Multidrug-Resistant Tuberculosis: A Retrospective Cohort Study.
    Chiang SS; Starke JR; Miller AC; Cruz AT; Del Castillo H; Valdivia WJ; Tunque G; García F; Contreras C; Lecca L; Alarcón VA; Becerra MC
    Clin Infect Dis; 2016 Oct; 63(8):1063-71. PubMed ID: 27458026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for unfavourable treatment outcomes among rifampicin-resistant tuberculosis patients in Tajikistan.
    Makhmudova M; Maxsumova Z; Rajabzoda A; Makhmadov A; van den Hof S; Mirtskhulava V
    Int J Tuberc Lung Dis; 2019 Mar; 23(3):331-336. PubMed ID: 30871664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient Characteristics Associated with Tuberculosis Treatment Default: A Cohort Study in a High-Incidence Area of Lima, Peru.
    Lackey B; Seas C; Van der Stuyft P; Otero L
    PLoS One; 2015; 10(6):e0128541. PubMed ID: 26046766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening outcomes from patients with suspected multidrug-resistant tuberculosis: lessons learned in the Philippines.
    Gler MT; Guilatco RS; Guray CV; Tupasi TE
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1326-30. PubMed ID: 22863522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health outcomes of bedaquiline in the treatment of multidrug-resistant tuberculosis in selected high burden countries.
    Lu X; Smare C; Kambili C; El Khoury AC; Wolfson LJ
    BMC Health Serv Res; 2017 Jan; 17(1):87. PubMed ID: 28122562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DOTS and DOTS-plus: not the only answer.
    Farmer P
    Ann N Y Acad Sci; 2001 Dec; 953():165-84. PubMed ID: 11795410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Multiple drug resistance: a threat for tuberculosis control].
    Cardoso EM
    Rev Panam Salud Publica; 2004 Jul; 16(1):68-73. PubMed ID: 15333267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of sputum culture conversion among patients treated for multidrug-resistant tuberculosis.
    Kurbatova EV; Gammino VM; Bayona J; Becerra MC; Danilovitz M; Falzon D; Gelmanova I; Keshavjee S; Leimane V; Mitnick CD; Quelapio MI; Riekstina V; Taylor A; Viiklepp P; Zignol M; Cegielski JP
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1335-43. PubMed ID: 23107633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.
    Putri FA; Burhan E; Nawas A; Soepandi PZ; Sutoyo DK; Agustin H; Isbaniah F; Dowdy DW
    Int J Tuberc Lung Dis; 2014 May; 18(5):564-70. PubMed ID: 24903794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment outcomes for multidrug-resistant tuberculosis under DOTS-Plus: a systematic review and meta-analysis of published studies.
    Kibret KT; Moges Y; Memiah P; Biadgilign S
    Infect Dis Poverty; 2017 Jan; 6(1):7. PubMed ID: 28093078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of cure among HIV co-infected multidrug-resistant TB patients at Sizwe Tropical Disease Hospital Johannesburg, South Africa.
    Umanah TA; Ncayiyana JR; Nyasulu PS
    Trans R Soc Trop Med Hyg; 2015 May; 109(5):340-8. PubMed ID: 25787727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru.
    Mitnick C; Bayona J; Palacios E; Shin S; Furin J; Alcántara F; Sánchez E; Sarria M; Becerra M; Fawzi MC; Kapiga S; Neuberg D; Maguire JH; Kim JY; Farmer P
    N Engl J Med; 2003 Jan; 348(2):119-28. PubMed ID: 12519922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis.
    Blöndal K; Viiklepp P; Guðmundsson LJ; Altraja A
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1228-33. PubMed ID: 22748131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment outcome and mortality among patients with multidrug-resistant tuberculosis in tuberculosis hospitals of the public sector.
    Jeon DS; Shin DO; Park SK; Seo JE; Seo HS; Cho YS; Lee JY; Kim DY; Kong SJ; Kim YS; Shim TS
    J Korean Med Sci; 2011 Jan; 26(1):33-41. PubMed ID: 21218027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TB "hot zones" emerging.
    Public Health Rep; 1998; 113(2):107. PubMed ID: 9719808
    [No Abstract]   [Full Text] [Related]  

  • 39. Tuberculosis control in Latvia: integrated DOTS and DOTS-plus programmes.
    Leimane V; Leimans J
    Euro Surveill; 2006; 11(3):29-33. PubMed ID: 16567876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of delayed culture conversion in patients treated for multidrug-resistant tuberculosis in Pakistan.
    Qazi F; Khan U; Khowaja S; Javaid M; Ahmed A; Salahuddin N; Hussain H; Becerra MC; Golub JE; Khan AJ
    Int J Tuberc Lung Dis; 2011 Nov; 15(11):1556-9, i. PubMed ID: 22008773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.